AHFS Drug Information Book explained

The AHFS DI is one of several compendiums^[1] approved by the Social Security Act (Section 1861(t)(2)(B)(ii)(I)) as a source of off-label anti-cancer drug use.^{[2] [3]} It was originally published in 1959 as the American Hospital Formulary Service (AHFS) by the American Society of Health-System Pharmacists.

It is also the only one left of the originally authorized compendiums.^[4]

References

1. Web site: And then there were five: CMS approves Wolters Kluwer Lexi-Drugs® as the fifth recognized authoritative compendium Lexology. ElizabethHalpern. Hogan Lovells-. Langbein. Stuart M.. en. 2018-03-30. Manning. Meredith. Roberts. Beth L.. Lakhani. Ali. 14 August 2015.
2. Web site: Medical Coverage Document. Centers for Medicare & Medicaid Services. cms.gov. 6 January 2018.
3. Web site: Role of Compendia in Determining what Drugs are Reimbursed. Abernethy. Amy. October 2012. National Science Foundation.
4. Butcher. Lola. 2008-06-25. Compendia Decisions Impact Off-Label Coverage. Oncology Times. en-US. 30. 12. 29–30. 10.1097/01.COT.0000326167.89228.b6. 0276-2234.

Further reading

• "Gain a solid understanding of compendia and its impact on patient access". Formulary Journal. 2012-07-01. Retrieved 2018-03-30.